Belviq vs. Saxenda

• Are Belviq and Saxenda the Same Thing?
• What Are Possible Side Effects of Belviq?
• What Are Possible Side Effects of Saxenda?
• What Is Belviq?
• What Is Saxenda?
• What Drugs Interact with Belviq?
• What Drugs Interact with Saxenda?
• How Should Belviq Be Taken?
• How Should Saxenda Be Taken?

Belviq(lorcaserin hydrochloride) andSaxenda(liraglutide [rDNA origin]) are used forchronicweight managementin成人用body mass index(BMI) of 30 or greater (obese) as an addition to a reduced-caloriediet and exercise and who have at least one weight-relatedconditionsuch as高血压(hypertension),type 2 diabetes, or highcholesterol(dyslipidemia).

Belviq and Saxenda belong to different drug classes. Belviq is aserotonin2Creceptoragonistand Saxenda is ananalogof human GLP-1 and acts as a GLP-1 receptor agonist.

Commonside effects的Belviq包括ude:

• 低血糖(hypoglycemia),
• mental problems,
• slow heartbeat,
• headache,
• dizziness,
• drowsiness,
• feelingtired,
• fatigue,
• nausea,
• dry mouth,
• cough,
• back pain,
• constipation,
• painful erections,
• diarrhea,
• vomiting,
• 上respiratorytractinfection,
• runny orstuffy nose,
• urinary tract infection,
• musclepain,
• sore throat, or
• rash.

Common side effects of Saxenda include:

• nausea,
• diarrhea,
• constipation,
• vomiting,
• lowblood sugar(hypoglycemia),
• decreased appetite,
• headache,
• dizziness,
• fatigue,
• abdominalorstomachpain or upset,
• indigestion,
• bloating,
• gas,
• urinary tractinfection,
• drymouth,
• changes intaste,
• gastroesophageal refluxdisease(GERD),
• belching,
• injection site reactions or redness,
• lack of energy or weakness,
• 肠胃炎,
• anxiety, or
• insomnia.

Belviq (lorcaserin hydrochloride) is a serotonin 2C receptor agonist indicated for the treatment of chronic weight management in adults with a body mass index (BMI) of 30 or greater (obese) as an addition to a reduced-calorie diet and exercise. Belviq is also approved for use by adults with a BMI of 27 or greater (overweight) and who have at least one weight-related condition such as highblood pressure(hypertension), type 2diabetes, or high cholesterol (dyslipidemia).

Saxenda (liraglutide [rDNA origin]) Injection is an analog of human GLP-1 and acts as a GLP-1 receptor agonist used for as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index (BMI) of 30 kg/m²or greater (obese), or 27 kg/m²or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2diabetes mellitus, or dyslipidemia).

Belviq may interact withantidepressants, including selective serotoninreuptakeinhibitors (SSRIs), serotonin-去甲肾上腺素reuptake inhibitors (SNRIs), monoamine oxidase inhibitors (MAOIs), triptans,bupropion,dextromethorphan, or St. John's Wort. Tell yourdoctorall medications you use.

Saxenda may interact with otheroralmedications taken at the same time. Tell your doctor all medications and supplements you use.

Belviq is taken orally. The recommended dosage of Belviq is one 10mg tablets taken twice per day. Belviq should be discontinued if 5%weight lossis not achieved by week 12 oftherapy.

The recommended dosage of Saxenda is 3mgdaily.